391 related articles for article (PubMed ID: 215465)
1. Modulation of human platelet function by prostacyclin and thromboxane A2.
Gorman RR
Fed Proc; 1979 Jan; 38(1):83-8. PubMed ID: 215465
[No Abstract] [Full Text] [Related]
2. Reciprocal regulation of human platelet cAMP levels by thromboxane A2 and prostacyclin.
Gorman RR; Fitzpatrick FA; Miller OV
Adv Cyclic Nucleotide Res; 1978; 9():597-609. PubMed ID: 208399
[No Abstract] [Full Text] [Related]
3. Effect of prostaglandins and thromboxane A2 on the contractility of rabbit splenic capsular smooth muscle.
Peskar BA; Förstermann U; Simmet T
Artery; 1980; 8(1):1-6. PubMed ID: 7000038
[TBL] [Abstract][Full Text] [Related]
4. Independence of the cyclic AMP-lowering activity of thromboxane A2 from the platelet release reaction.
Gorman RR; Wierenga W; Miller OV
Biochim Biophys Acta; 1979 Jan; 572(1):95-104. PubMed ID: 216409
[No Abstract] [Full Text] [Related]
5. Prostaglandins and thromboxanes: "middlemen" modulating platelet function in hemostasis and thrombosis.
Gerrard JM; White JG
Prog Hemost Thromb; 1978; 4():87-125. PubMed ID: 213813
[No Abstract] [Full Text] [Related]
6. Thromboxane A2, prostacyclin and aspirin: effects on vascular tone and platelet aggregation.
Smith JB; Araki H; Lefer AM
Circulation; 1980 Dec; 62(6 Pt 2):V19-25. PubMed ID: 7002350
[TBL] [Abstract][Full Text] [Related]
7. Reversal of thromboxane A2/prostaglandin H2 and ADP-induced calcium release in intact platelets.
Brace LD; Venton DL; Le Breton GC
Am J Physiol; 1985 Jul; 249(1 Pt 2):H8-13. PubMed ID: 2409821
[TBL] [Abstract][Full Text] [Related]
8. Acetyl glycerylphosphorylcholine inhibition of prostaglandin I2-stimulated adenosine 3',5'-cyclic monophosphate levels in human platelets. Evidence for thromboxane A2 dependence.
Miller OV; Ayer DE; Gorman RR
Biochim Biophys Acta; 1982 Jun; 711(3):445-51. PubMed ID: 6285985
[TBL] [Abstract][Full Text] [Related]
9. 7-Oxabicyclo[2.2.1]heptane analogs as modulators of the thromboxane A2 and prostacyclin receptors.
Sprague PW; Heikes JE; Harris DN; Greenberg R
Adv Prostaglandin Thromboxane Leukot Res; 1983; 11():337-43. PubMed ID: 6303073
[No Abstract] [Full Text] [Related]
10. Regulation of human lymph contractility by prostaglandins and thromboxane.
Sinzinger H; Kaliman J; Mannheimer E
Lymphology; 1984 Jun; 17(2):43-5. PubMed ID: 6381904
[TBL] [Abstract][Full Text] [Related]
11. Pharmacological interactions between prostacyclin and thromboxanes.
Whittle BJ; Moncada S
Br Med Bull; 1983 Jul; 39(3):232-8. PubMed ID: 6313114
[No Abstract] [Full Text] [Related]
12. Pharmacology and endogenous roles of prostaglandin endoperoxides, thromboxane A2, and prostacyclin.
Moncada S; Vane JR
Pharmacol Rev; 1978 Sep; 30(3):293-331. PubMed ID: 116251
[No Abstract] [Full Text] [Related]
13. Biochemical and pharmacological evaluation of thromboxane synthetase inhibitors.
Gorman RR
Adv Prostaglandin Thromboxane Res; 1980; 6():417-25. PubMed ID: 6247892
[No Abstract] [Full Text] [Related]
14. The generation of TXA2 in human platelet rich plasma and its inhibition by nictindole and prostacyclin.
Grodzińska L; Marcinkiewicz E
Pharmacol Res Commun; 1979 Feb; 11(2):133-46. PubMed ID: 375247
[No Abstract] [Full Text] [Related]
15. Pinane thromboxane A2: a TXA2 antagonist with antithrombotic properties.
Aharony D; Smith JB; Smith EF; Lefer AM; Magolda RL; Nicolaou KD
Adv Prostaglandin Thromboxane Res; 1980; 6():489-92. PubMed ID: 6992538
[No Abstract] [Full Text] [Related]
16. Influence of selective thromboxane synthetase blocker CGS-13080 on thromboxane and prostacyclin biosynthesis in whole blood: evidence for synthesis of prostacyclin by leukocytes from platelet-derived endoperoxides.
Mehta J; Mehta P; Lawson DL; Ostrowski N; Brigmon L
J Lab Clin Med; 1985 Sep; 106(3):246-52. PubMed ID: 3928780
[TBL] [Abstract][Full Text] [Related]
17. Biological effects of 15-hydroperoxythromboxane A2 on platelets and aorta.
Hammarström S
Prostaglandins Med; 1980 May; 4(5):297-302. PubMed ID: 7403329
[TBL] [Abstract][Full Text] [Related]
18. Thromboxane A2/prostaglandin H2 mobilizes calcium in human blood platelets.
Brace LD; Venton DL; Le Breton GC
Am J Physiol; 1985 Jul; 249(1 Pt 2):H1-7. PubMed ID: 3925795
[TBL] [Abstract][Full Text] [Related]
19. Thromboxane synthetase inhibition results in increased platelet sensitivity to prostacyclin.
Bertelé V; Falanga A; Roncaglioni MC; Cerletti C; de Gaetano G
Thromb Haemost; 1982 Jun; 47(3):294. PubMed ID: 7051411
[No Abstract] [Full Text] [Related]
20. Endogenous prostacyclin contributes to the efficacy of a thromboxane synthetase inhibitor for preventing coronary artery thrombosis.
Aiken JW; Shebuski RJ; Miller OV; Gorman RR
J Pharmacol Exp Ther; 1981 Nov; 219(2):299-308. PubMed ID: 6270303
[No Abstract] [Full Text] [Related]
[Next] [New Search]
